Neri Jesse 4

What Happened

• Jesse Neri, SVP and Chief Financial Officer of Rockwell Medical, was granted 15,000 restricted stock units (RSUs) on July 1, 2026. The grant is reported as an award (code A) at $0.00 per share (compensation award, not an open-market purchase).
• The RSUs vest in three equal annual installments (5,000 RSUs each) on the first, second and third anniversaries of July 1, 2026, subject to Neri’s continued service.

Key Details

• Transaction date: 2026-07-01; reported on Form 4 filed 2026-07-06.
• Price reported: $0.00 per share (award/compensation grant).
• Vesting: three equal installments of 5,000 RSUs on each of the first three anniversaries of the grant date (subject to continued service).
• Reverse split adjustment: A 1-for-10 reverse stock split became effective at 12:01 AM on July 1, 2026; the filing notes proportionate adjustments to outstanding equity awards and that reported share figures reflect the split.
• Filing timeliness: Form 4 was filed July 6, 2026 (no late-filing indicator shown in the provided data).
• Shares owned after transaction: not specified in the data provided.

Context

• RSU grants are compensation and do not represent an open-market purchase or sale; they vest over time and generally cannot be sold until vested (unless specified otherwise).
• The reverse split reduced reported share counts and adjusted outstanding awards proportionally; the 15,000-RSU figure in this filing already reflects that adjustment.